[go: up one dir, main page]

MXPA99002575A - Composicion para la inhibicion viral, que comprende amidas, acidos grasos, alcanos y alcoholes de cadena larga. - Google Patents

Composicion para la inhibicion viral, que comprende amidas, acidos grasos, alcanos y alcoholes de cadena larga.

Info

Publication number
MXPA99002575A
MXPA99002575A MXPA99002575A MX9902575A MXPA99002575A MX PA99002575 A MXPA99002575 A MX PA99002575A MX PA99002575 A MXPA99002575 A MX PA99002575A MX 9902575 A MX9902575 A MX 9902575A MX PA99002575 A MXPA99002575 A MX PA99002575A
Authority
MX
Mexico
Prior art keywords
alkanes
amides
fatty acids
alcohol
long
Prior art date
Application number
MXPA99002575A
Other languages
English (en)
Inventor
David H Katz
Original Assignee
Avanir Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/916,624 external-priority patent/US5952392A/en
Application filed by Avanir Pharmaceuticals filed Critical Avanir Pharmaceuticals
Publication of MXPA99002575A publication Critical patent/MXPA99002575A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se describen composiciones terapeuticas que incluyen un tensioactivo no ionico combinado con acidos grasos, alcanos, amidas o alcoholes mono-insaturados de cadena larga, particularmente alcohol estearilico, alcohol erucilico, alcohol brassilico, alcohol araquidilico, n-docosano, acido n-docosanoico, erucamida y acido estearico o mezclas de los mismos, ingredientes activos. Se describen los metodos para evitar o tratar las infecciones virales, el tratamiento de la inflamacion de la piel o las membranas ola inhibicion de la proliferacion celular utilizando tales composiciones.
MXPA99002575A 1996-09-17 1997-09-10 Composicion para la inhibicion viral, que comprende amidas, acidos grasos, alcanos y alcoholes de cadena larga. MXPA99002575A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71500996A 1996-09-17 1996-09-17
US08/916,624 US5952392A (en) 1996-09-17 1997-08-22 Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
PCT/US1997/016007 WO1998011887A2 (en) 1996-09-17 1997-09-10 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides

Publications (1)

Publication Number Publication Date
MXPA99002575A true MXPA99002575A (es) 2004-07-29

Family

ID=27109257

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA99002575A MXPA99002575A (es) 1996-09-17 1997-09-10 Composicion para la inhibicion viral, que comprende amidas, acidos grasos, alcanos y alcoholes de cadena larga.

Country Status (16)

Country Link
EP (2) EP1557167A1 (es)
JP (1) JP3739098B2 (es)
KR (2) KR100528815B1 (es)
CN (1) CN1213748C (es)
AT (1) ATE299700T1 (es)
AU (1) AU742929B2 (es)
BR (1) BR9711501A (es)
CA (1) CA2273960C (es)
DE (1) DE69733778T2 (es)
DK (1) DK1001759T3 (es)
ES (1) ES2245004T3 (es)
IL (2) IL129033A0 (es)
MX (1) MXPA99002575A (es)
PL (1) PL189618B1 (es)
PT (1) PT1001759E (es)
WO (1) WO1998011887A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
AP1209A (en) 1996-11-14 2003-09-30 Lipomedica Ehf Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglceride derivatives thereof for treating of mucosa infections.
ES2202872T3 (es) 1997-06-20 2004-04-01 Prometics Bodycare Limited Composicion protectora de la piel.
IL142535A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
SE0102289D0 (sv) * 2001-06-27 2001-06-27 Anders Hamberger New use of compound
HRP20040421B1 (hr) * 2001-10-16 2013-05-31 Avanir Pharmaceuticals INHIBICIJA VIRUSA n-DOKOZANOLOM
NZ539106A (en) 2002-10-10 2007-02-23 Yeda Res & Dev Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents
KR200449517Y1 (ko) * 2008-01-23 2010-07-15 김영중 선박의 조향장치용 헬름
KR100971276B1 (ko) * 2008-05-29 2010-07-20 김영중 조향장치
US9242923B2 (en) 2010-03-11 2016-01-26 Chemic Laboratories Inc. Compositons and methods
CN102702061B (zh) * 2012-06-07 2013-04-24 浙江维康药业有限公司 一种盐酸水苏碱化合物及含有该化合物的药物组合物
JP6125962B2 (ja) * 2013-09-24 2017-05-10 株式会社デンソー 抗ウイルス剤
FR3080038B1 (fr) 2018-04-16 2020-10-09 Oreal Composition cosmetique pour fibres keratiniques
FR3080034B1 (fr) * 2018-04-16 2020-04-24 L'oreal Composition cosmetique pour fibres keratiniques
KR102611242B1 (ko) * 2021-05-17 2023-12-08 충남대학교 산학협력단 알케인을 유효성분으로 함유하는 항바이러스용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
US5194451A (en) * 1989-11-02 1993-03-16 Katz David H Systemic anti-inflammatory treatment
US5250236A (en) * 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution
CA2153780C (en) * 1993-01-15 2004-04-13 Micro Vesicular Systems, Inc. Method of inhibiting viral reproduction
US5534554A (en) * 1993-12-13 1996-07-09 Lidak Pharmaceuticals Sucrose ester-C20 to C28 alcohol formulations

Also Published As

Publication number Publication date
CA2273960C (en) 2003-12-30
CA2273960A1 (en) 1998-03-26
PL189618B1 (pl) 2005-08-31
DE69733778D1 (de) 2005-08-25
PL332455A1 (en) 1999-09-13
CN1213748C (zh) 2005-08-10
WO1998011887A3 (en) 1998-06-25
DE69733778T2 (de) 2006-04-20
AU742929B2 (en) 2002-01-17
EP1001759A2 (en) 2000-05-24
KR20030097605A (ko) 2003-12-31
PT1001759E (pt) 2005-10-31
KR20000036210A (ko) 2000-06-26
EP1557167A1 (en) 2005-07-27
JP2001521490A (ja) 2001-11-06
IL163865A0 (en) 2005-12-18
IL129033A0 (en) 2000-02-17
KR100528816B1 (ko) 2005-11-16
DK1001759T3 (da) 2005-10-10
KR100528815B1 (ko) 2005-11-16
AU4339797A (en) 1998-04-14
WO1998011887A2 (en) 1998-03-26
BR9711501A (pt) 2004-05-25
ATE299700T1 (de) 2005-08-15
JP3739098B2 (ja) 2006-01-25
CN1244121A (zh) 2000-02-09
ES2245004T3 (es) 2005-12-16
EP1001759B1 (en) 2005-07-20

Similar Documents

Publication Publication Date Title
MXPA99002575A (es) Composicion para la inhibicion viral, que comprende amidas, acidos grasos, alcanos y alcoholes de cadena larga.
ES2170256T3 (es) Composiciones para el suministro topico de ingredientes activos.
ES2154650T3 (es) Composicion que comprende una formulacion con factor de coagulacion viii, procedimiento para su preparacion y uso de un tensioactivo como estabilizador.
MX9207449A (es) Inhibidores de la enzima proteolitica derivada de sacarina.
NZ308293A (en) Antibacterial-wound healing compositions comprising a pyruvate, antioxidant and fatty acids
EP0730465A4 (en) USE OF ANGIOTENSIN III AND ITS ANALOGS FOR TISSUE REPAIR
NO20000085L (no) Forbedrede fremgangsmåter og preparater for behandling av ereksjonsdysfunksjon hos menn
NZ295303A (en) Sunscreen composition comprising a sunscreen agent, an anti-inflammatory agent and a composition for healing wounds
ES2189768T3 (es) Sintesis regioselectiva de derivados de rapamicina.
IL114641A0 (en) Pharmaceutical compositions containing fluoxetine
BR9507730A (pt) Uso de formulações em gel como composições de tratamento
MX9606502A (es) Composiciones antiqueratoliticas y curativas para heridas y metodos para preparar y utilizar las mismas.
ES2068797T3 (es) Producto para el tratamiento del cabello y procedimiento para su aplicacion.
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
ES2161759T3 (es) Derivados de profarmacos de inhibidores de enzimas con grupos hidroxilo, procedimiento para su preparacion y su utilizacion.
DK0713386T3 (da) Sprayformulering med kølende effekt
CA2445953A1 (en) VIRAL INHIBITION USING ALCOHOLS, ALKANES, FATTY ACIDS AND LONG CHAIN AMIDES
AU5957198A (en) A process for inhibiting stem elongation in bulbous plants
DK1087658T3 (da) Biologisk aktiv mikrodispersionssammensætning
ES2113803A1 (es) Metodo para el tratamiento de plantas.
AR022017A1 (es) Un agente para tratar el trastorno de la funcion de las celulas visuales. el metodo de tratamiento y el uso de dicho agente para la produccion de unacomposicion farmaceutica
UY26514A1 (es) " composición para el tratamiento de tejidos danados".
DK0925064T3 (da) 5-Androsten-3-beta,17-alpha-diol som inhibitor for tumorvækst
JPS53113025A (en) Proliferation inhibitor for microorganisms
MD1218F1 (en) Antimutagenic agent